Sarepta Therapeutics Inc (SRPT)

Receivables turnover

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue US$ in thousands 1,243,340 933,013 701,887 540,099 380,833
Receivables US$ in thousands 403,058 217,939 152,990 101,340 90,879
Receivables turnover 3.08 4.28 4.59 5.33 4.19

December 31, 2023 calculation

Receivables turnover = Revenue ÷ Receivables
= $1,243,340K ÷ $403,058K
= 3.08

Sarepta Therapeutics Inc's receivables turnover has been variable over the past five years. The trend indicates a decrease in efficiency in collecting receivables from customers. The company's receivables turnover ratio decreased from 4.19 in 2019 to 3.08 in 2023. This suggests that it took longer for Sarepta Therapeutics Inc to collect payments from customers in 2023 compared to previous years. A lower receivables turnover ratio may indicate potential issues with credit policies, collection efforts, or the creditworthiness of customers. It is important for the company to monitor and improve its receivables turnover to ensure the efficient management of its accounts receivable and cash flow.


Peer comparison

Dec 31, 2023